GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InflaRx NV (NAS:IFRX) » Definitions » 5-Year Yield-on-Cost %

InflaRx NV (InflaRx NV) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 01, 2024)


View and export this data going back to 2017. Start your Free Trial

What is InflaRx NV 5-Year Yield-on-Cost %?

InflaRx NV's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for InflaRx NV's 5-Year Yield-on-Cost % or its related term are showing as below:



IFRX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.75
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of InflaRx NV's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, InflaRx NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where InflaRx NV's 5-Year Yield-on-Cost % falls into.



InflaRx NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of InflaRx NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

InflaRx NV  (NAS:IFRX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


InflaRx NV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of InflaRx NV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


InflaRx NV (InflaRx NV) Business Description

Traded in Other Exchanges
Address
Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.